All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
CADRENAL THERAPEUTICS, INC. Last Reported: 10/31/2024 Stock Symbol: CVKD

Business Address

822 A1A NORTH
SUITE 300
PONTE VEDRA , FL US 32082

Mailing Address

822 A1A NORTH
SUITE 300
PONTE VEDRA , FL US 32082
Phone Number: 904-300-0701 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 12/31/2022 11/30/2022 5/31/2022
Cash and Cash Equivalents $4,363,900.00 $5,037,174.00 $6,566,418.00 $9,109,445.00 -- -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets -- -- -- -- -- -- -- --
Total Current Assets $4,672,490.00 $5,443,504.00 $7,028,029.00 $9,278,047.00 $3,519,134.00 $727,596.00 -- --
Property Plant and Equipement $814.00 $1,220.00 $1,690.00 $2,884.00 $3,480.00 $1,013.00 -- --
Intangible Assets Net -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- --
Other Assets $3,792.00 $3,792.00 $3,792.00 $3,792.00 $3,792.00 $5,987.00 -- --
Total Assets $4,679,293.00 $5,457,171.00 $7,048,431.00 $9,311,618.00 $3,559,026.00 $778,174.00 -- --
Accounts Payable $496,823.00 $759,518.00 $400,373.00 $141,658.00 $78,139.00 $404,897.00 -- --
Accrued Liabilities $767,887.00 $696,603.00 $440,775.00 $396,917.00 $272,106.00 $863,564.00 -- --
Total Current Liabilities $1,266,942.00 $1,464,917.00 $856,315.00 $565,798.00 $383,104.00 $6,329,324.00 -- --
Long Term Debt -- -- -- -- -- -- -- --
Additional Paid-in Capital -- $23,103,931.00 $22,910,811.00 -- -- -- -- $100,000.00
Accumulated Other Comprehensive Loss -- -- -- -- -- -- -- --
Accumulated Deficit $-21,535,514.00 $-19,127,685.00 $-16,734,703.00 $-13,927,355.00 $-12,890,904.00 $-6,714,329.00 -- --
Total Stockholders' Equity $3,412,351.00 $3,992,254.00 $6,192,116.00 $8,745,820.00 $3,175,922.00 $-5,551,150.00 -- --
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- --
Total Liabilities and Equity $4,679,293.00 $5,457,171.00 $7,048,431.00 $9,311,618.00 $3,559,026.00 $778,174.00 -- --

Statement of Operations

Date 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 12/31/2022 11/30/2022 5/31/2022
Total Revenues -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- --
Research and Development $2,667,382.00 $1,253,711.00 $629,025.00 $243,948.00 $185,537.00 $136,802.00 -- --
Selling, General, and Administrative -- -- -- -- -- -- -- --
Total Operating Expenses $6,682,191.00 $2,466,618.00 $1,755,615.00 $6,369,012.00 $1,026,177.00 $2,701,628.00 -- --
Loss from Operations $-2,459,958.00 $-2,466,618.00 $-1,755,615.00 $-6,369,012.00 $-1,026,177.00 $-2,701,628.00 -- --
Loss Before Income Taxes -- -- -- -- -- -- -- --
Earnings Per Share Basic $-5.99 $-0.15 $-0.10 $-0.07 $-0.09 $-0.85 -- --
Weighted Average Shares Basic 1,079,489 16,008,469 16,008,469 15,396,224 11,722,754 7,890,507 -- --
Earnings Per Share Diluted $-5.99 $-0.15 $-0.10 $-0.57 $-0.09 $-0.85 -- --
Weighted Average Shares Diluted 1,079,489 16,008,469 16,008,469 15,396,224 11,252,903 7,890,507 -- --
Common Stock Shares Authorized 75,000,000 75,000,000 75,000,000 75,000,000 75,000,000 75,000,000 -- --
Common Stock Shares Outstanding 1,234,672 16,008,469 16,008,469 13,022,754 11,722,754 8,193,875 -- --
Common Stock Value $1,234.00 $16,008.00 $16,008.00 $13,022.00 $11,722.00 $8,194.00 -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 7,500,000 7,500,000 -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- 7,500,000 -- -- -- 7,500,000 --
Preferred Stock Value -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 -- -- -- $0.00 --
Share Price -- -- -- -- -- $6.00 -- --
Copyright 2025 PursePoor.com